Russell Scott - Researcher Profile | RDL Research Database

Publications

2 shown

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Jennifer B. Green , M. Angelyn Bethel , Paul W. Armstrong +16 more

Among patients with type 2 diabetes and established cardiovascular disease, adding sitagliptin to usual care did not appear to increase the risk of major adverse cardiovascular ...

2015 New England Journal of Medicine 2519 citations

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Frederick J. Raal , Evan A. Stein , Robert Dufour +15 more

2014 The Lancet 730 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,249
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2107-6480

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.